Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 22 Jul 2021
Dupixent (dupilumab injection) receives positive recommendation from CADTH and INESSS for the treatment of severe asthma
22 July 2021 - Recommendation supported by multiple clinical trials that demonstrated a reduced frequency of asthma exacerbations compared to placebo, ...
Posted by Michael Wonder on 22 Jul 2021
Biogen sees heavy patient interest in new Alzheimer’s drug
22 July 2021 - Company pushed back against criticism of drug’s effectiveness and approval, saying trial data supported use. ...
Posted by Michael Wonder on 22 Jul 2021
More community pharmacies and additional GPs to deliver COVID-19 vaccines
22 July 2021 - Thousands of community pharmacies and additional GPs across Australia will be invited to join the COVID-19 vaccine ...
Posted by Michael Wonder on 22 Jul 2021
TGA set to greenlight Pfizer jab for children aged between 12 and 16 year old
23 July 2021 - Australia’s drug regulator is reportedly set to greenlight the Pfizer COVID vaccine for the country’s children, ...
Posted by Michael Wonder on 22 Jul 2021
FDA approves treatment for paediatric patients with type 2 diabetes mellitus
22 July 2021 - The U.S. FDA today approved Bydureon and Bydureon BCise (exenatide extended release) injection to be used in ...
Posted by Michael Wonder on 22 Jul 2021
Astra blitz: Scott Morrison says get the COVID-19 vaccine now
22 July 2021 - Scott Morrison has apologised for the nation’s behind schedule vaccine program and told young people the ...
Posted by Michael Wonder on 22 Jul 2021
NHS England unveils new Innovative Medicine Fund
21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...
Posted by Michael Wonder on 22 Jul 2021
ICER releases draft evidence report on therapies for myasthenia gravis
22 July 2021 - Public comment period now open until 18 August 2021; requests to make oral comment during public meeting ...
Posted by Michael Wonder on 22 Jul 2021
Roche is discussing Alzheimer’s drug with FDA following regulators controversial approval of Biogen’s Aduhelm, CEO says
22 July 2021 - Roche is discussing its potential Alzheimer’s treatment with the U.S. FDA, CEO Severin Schwan said Thursday, ...
Posted by Michael Wonder on 22 Jul 2021
FDA approves Keytruda (pembrolizumab) plus Lenvima (lenvatinib) combination for patients with certain types of advanced endometrial carcinoma
22 July 2021 - Immunotherapy and tyrosine kinase inhibitor combination approved for the treatment of patients with advanced endometrial carcinoma that ...
Posted by Michael Wonder on 22 Jul 2021
Bayer’s new symptomatic chronic heart failure treatment Verquvo (vericiguat) approved in EU
21 July 2021 - Approved for adult patients with reduced ejection fraction who are stabilised after a recent decompensation event requiring ...
Posted by Michael Wonder on 22 Jul 2021
Patients with rare bile duct cancer set to benefit from life extending treatment
22 July 2021 - Some people who have a rare form of bile duct cancer are set to benefit from life-extending ...
Posted by Michael Wonder on 22 Jul 2021
bluebird bio receives EC approval for Skysona (elivaldogene autotemcel, Lenti-D) gene therapy for patients less than 18 years of age with early cerebral adrenoleukodystrophy without matched sibling donor
21 July 2021 - Skysona is the first and only gene therapy approved in the European Union to treat early CALD. ...
Posted by Michael Wonder on 22 Jul 2021
RareStone announces submission of new drug application of Wakix (pitolisant) for narcolepsy with and without cataplexy in China
21 July 2021 - Application is supported by data used in the Wakix EMA and the U.S. FDA approvals. ...
Posted by Michael Wonder on 22 Jul 2021
COVID-19 vaccine weekly safety report (22 July 2021)
22 July 2021 - Over the last week, four additional cases of blood clots with low blood platelets have been assessed ...